Category: Team Pump
-
We told you so: Aphria (APHA.T) and Green Growth Brands (GGB) terminate bullshit takeover bid
In the days earlier this year, when it became clear from a short seller report that Aphria (APHA.T) had bought into foreign assets that were largely ‘early stage’ if you were being charitable, and ‘fake’ if you weren’t, the company went through four stages of denial. The takeover bid was bullshit from the outset, a…
-
Aphria (APHA.T) puts out financial results, falls on face, walks into pole
Well, I guess we were right, huh? Big Canadian cannabis producer Aphria (APHA.T), fresh off a scandal involving allegations from the short sellers the company was overpaying for garbage assets their top execs part owned, released their first financials today since the scandal broke. It was so unpretty, interested observers had to get through the…
-
Cannara Biotech (LOVE.C) makes MedMen look like a charitable institution
Cannara Biotech (LOVE.C) is a pig. I mean, okay. Pigs are actually kind of cool, they’re smart and bacon tastes good and they like a tummy rub, so Cannara is not actually a pig. But it is a trap for your money, and you should ideally not play with money traps because their sole purpose is,…
-
Aphria (APHA.T) ‘Special Committee’ confirms short seller conflict of interest allegations
Several months ago, Aphria (APHA.T) lost a good chunk of its worth when short sellers accused the company executive and board of (in a nutshell) feathering their own nests by agreeing to acquire properties from themselves, for much inflated prices. Today, after a ridiculously long wait which involved the CEO stepping sideways from his position…
-
Weed company house cleaning: Bonify loses its LP license but grownups are emerging
“We couldn’t be happier to let registered patients know that they can now buy direct from Bonify, a company that truly puts its customers at the core of everything we do,” said company CEO and President Dalbir Bains, back in June 2018, when the company got its Health Canada cannabis sales license. “With the Canadian…
-
Instadose: Mistakes were made, but company makes commitment to oversight and improvement
[UPDATE]: The article below is one that we have stood behind from the day we posted it, and do to this day. What it shows is how a young company, one without the oversight of a more mature outfit, can make rash decisions and overpromise in a way that they hope will allow them to…
-
Xmas news dump: Aphria (APHA.T) subject to ‘unfriendly’ takeover by company CEO advises
This Aphria (APHA.T) story just keeps getting richer, and the unbelievable lack of respect this company is giving the market and regulators is a sight to behold. Let’s recap the last few weeks: So now we’re into the dead days of the 2018 market, just after Christmas and right before New Year, when few are…
-
Enough is enough: Time for Aphria’s (APHA.T) CEO Vic Neufeld to resign or be fired
It’s time to end the charade. Canadian licensed cannabis producer Aphria (APHA.T) has long been considered one of the ‘big three’ in the North American scene, which helped them benefit from institutional investment, pension fund allocations, and ETF involvement, and contributed to a long rising market cap that topped out in January 2017 at around $5…
-
Tepid Aphria (APHA.T) response to short report accusations sees stock hammered – again
It’s all gone pear-shaped over at Aphria (APHA.T) a day after a short report was filed by Quintessential Capital Management, following up on an earlier short report by Hindenburg Research. In the report, admitted short sellers claimed they’d traveled the globe looking for companies and properties Aphria purchased, sometimes from companies that board members owned…